DK1250422T3 - Myeloid-kolonistimulerende faktor og anvendelser deraf - Google Patents

Myeloid-kolonistimulerende faktor og anvendelser deraf

Info

Publication number
DK1250422T3
DK1250422T3 DK01905087T DK01905087T DK1250422T3 DK 1250422 T3 DK1250422 T3 DK 1250422T3 DK 01905087 T DK01905087 T DK 01905087T DK 01905087 T DK01905087 T DK 01905087T DK 1250422 T3 DK1250422 T3 DK 1250422T3
Authority
DK
Denmark
Prior art keywords
stimulating factor
myeloid colony
csf5
hyaluronidase
diseases
Prior art date
Application number
DK01905087T
Other languages
English (en)
Inventor
Gregory I Frost
Per Borgstrom
Original Assignee
Sidney Kimmel Cancer Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidney Kimmel Cancer Ct filed Critical Sidney Kimmel Cancer Ct
Application granted granted Critical
Publication of DK1250422T3 publication Critical patent/DK1250422T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK01905087T 2000-01-25 2001-01-25 Myeloid-kolonistimulerende faktor og anvendelser deraf DK1250422T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17791300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
DK1250422T3 true DK1250422T3 (da) 2006-05-29

Family

ID=22650424

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01905087T DK1250422T3 (da) 2000-01-25 2001-01-25 Myeloid-kolonistimulerende faktor og anvendelser deraf

Country Status (9)

Country Link
EP (1) EP1250422B1 (da)
JP (1) JP2004500079A (da)
AT (1) ATE315082T1 (da)
AU (1) AU784155B2 (da)
CA (1) CA2398539C (da)
DE (1) DE60116466T2 (da)
DK (1) DK1250422T3 (da)
ES (1) ES2259024T3 (da)
WO (1) WO2001055357A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004024041D1 (de) 2003-03-05 2009-12-24 Halozyme Inc Lösliches hyaluronidase-glycoprotein (shasegp), verfahren zu seiner herstellung, verwendungen und dieses enthaltende pharmazeutische zusammensetzungen
KR101454646B1 (ko) 2012-11-05 2014-10-27 (주)한국비엠아이 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123938A (en) * 1996-10-17 2000-09-26 The Regents Of The University Of California Human urinary hyaluronidase

Also Published As

Publication number Publication date
WO2001055357A3 (en) 2002-03-28
EP1250422A2 (en) 2002-10-23
AU3300401A (en) 2001-08-07
AU784155B2 (en) 2006-02-09
ES2259024T3 (es) 2006-09-16
CA2398539C (en) 2011-05-31
EP1250422B1 (en) 2006-01-04
JP2004500079A (ja) 2004-01-08
DE60116466D1 (de) 2006-03-30
ATE315082T1 (de) 2006-02-15
DE60116466T2 (de) 2006-09-28
WO2001055357A2 (en) 2001-08-02
CA2398539A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
NO20024157L (no) Kasein-avledete peptider og anvendelser derav i terapi
WO2001090129A3 (en) Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
EP0753053A1 (en) ALPHAVIRUS cDNA VECTORS
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
MX9603925A (es) Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas.
MXPA02005563A (es) Formulacion estable de interferon en solucion acuosa, metodo de preparacion y usos de la misma.
PL375113A1 (en) Casein derived peptides and uses thereof in therapy
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
DK1250422T3 (da) Myeloid-kolonistimulerende faktor og anvendelser deraf
MD990258A (en) Method of treatment of the acute viral hepatitis B
WO2001045738A3 (en) Use of heat shock proteins to enhance production of chemokines by a cell
MXPA04007491A (es) Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores.
DE602004025683D1 (de) Therapeutische zubereitung für autoimmune erkrankungen
AU2003253888A1 (en) Combination therapies with l-fmau for the treatment of hepatitis b virus infection
WO2003072750A3 (en) Expression of hiv-related proteins in plants
JPS6455143A (en) Production of milk powder for nursing which is endowed with phylactic ability
WO2024040030A3 (en) Treating protein misfolding disorders
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
AU4300700A (en) Inactivated cytokines for immunisation
EP1734050A3 (en) Immunization of dairy cattle with GapC protein against streptococcus infection
GR950100316A (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος.
WO2001075001A3 (fr) Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide
UA34283A (uk) Спосіб діагностики порушень імунологічного статусу у людини та тварин
UA30787A (uk) Спосіб лікування хронічного персистуючого гепатиту
WO2001075042A3 (fr) Nouveau polypeptide, serine hydrolase humaine atp-dependante 9, et polynucleotide codant pour ce polypeptide